University of California, Irvine School of Medicine

About the School of Medicine
Ranked as one of the top 50 U.S. medical schools for research by U.S. News & World Report, University of California, Irvine's School of Medicine is dedicated to advancing medical knowledge and clinical practice through scholarly research, physician education and high-quality care. The medical school nurtures the development of medical students, resident physicians and scholars in the clinical and basic sciences and supports the dissemination of research advances for the benefit of society.

School of Medicine Facts

• Each year, the school educates more than 400 medical students and trains more than 600 residents and fellows at UC Irvine Medical Center and affiliated institutions.
• The school's 560 full-time and 1,300 volunteer faculty members are involved in teaching, providing medical care and conducting research into the health challenges facing the 21st century.
• The school has 26 departments, ranging from basic science research to clinical medical and surgical specialties. It has research, clinical and teaching relationships with the Long Beach Veterans Administration Medical Center and Long Beach Memorial Medical Center.
• The school offers an MD degree, a combined MD/PhD medical scientist training program, a master's degree in genetic counseling, a combined MD/MBA program with The Paul Merage School of Business and a unique combined MD/master's program called the Program in Medical Education for the Latino Community (PRIME-LC).

UC Irvine Medical Center
UC Irvine Medical Center is the principal clinical facility for the School of Medicine's teaching and research programs. In early 2009, UC Irvine opened UC Irvine Douglas Hospital, a modern facility for conducting the latest medical research and training future and practicing physicians. The seven-story hospital has spacious, mostly private rooms and 15 state-of-the-art operating rooms. In addition, the hospital provides an environment for translational research allowing more opportunities for researchers and clinicians to collaborate on patient care.

The School of Medicine's close research, clinical and teaching relationship with UC Irvine Medical Center has helped position UC Irvine Healthcare, the clinical entity of UC Irvine, as a leader in translational medicine. UC Irvine Healthcare uses the latest clinical research, including studies pioneered by UC Irvine researchers, to provide patients with the most advanced therapies and treatments.

Message from the Dean
Ralph V. Clayman, M.D., an innovative leader in urology and minimally invasive surgery, became dean of UC Irvine School of Medicine in December, 2009. Since he assumed the post, he has worked with the faculty to invigorate the academic, research and clinical missions of the School of Medicine.

When Clayman came to UC Irvine in 2002 to start its Department of Urology, he already was a prolific researcher and pioneer in minimally invasive techniques that have revolutionized kidney and urinary tract surgical procedures and dramatically improved patient outcomes. The department is ranked among the nation's top 30 in U.S. News & World Report's annual "Best Hospitals" issue. Many of the department's doctors are rated nationally among the best in their field. UC Irvine is now a major center for minimally invasive robotic and laparoscopic surgery, and is home to the first mini-residency program for teaching urological surgeons the latest techniques.

Clayman came to UC Irvine from Washington University in St. Louis, where he was professor of surgery and radiology and medical director of the Midwest Stone Institute. There he and his colleagues pioneered techniques in less invasive therapies for kidney stones and performed the world's first removal of a tumor bearing kidney using a laparoscope. They subsequently expanded the technique to include a broad variety of renal surgery for cancer and benign disease.

Clayman has invented more than a dozen devices for performing minimally invasive surgical procedures. His laboratory studies are directed at the use of cryotherapy for treating renal cancer and other minimally invasive technologies to improve patient outcomes.

"I am honored and invigorated by this opportunity to promote the excellence of the School of Medicine and its superb medical campus to the Orange County community and beyond," Clayman said when he became dean.

Admissions
The University of California School of Medicine admits 104 students each year into their first-year class from over 5,000 applicants. Included in each first year class are six Medical Scientist Training Program (MSTP) students, who will receive a Ph.D. in addition to their M.D. In addition, 12 students are part of the Program in Medical Education for the Latino Community (PRIME-LC).

These students will obtain a masters degree and an M.D. upon completion of their training to become leaders in health care in the underserved Latino communities. Once in medical school, approximately 25% of our student body prior to graduation from medical school obtain other degrees, e.g. an MBA or MPH, or take time to gain additional research experience.

Selection of each class is based on several factors including academics, involvement in research, clinical exposure, community service, and extracurricular activities. Leadership and personal qualities, as determined by interviews and letters of recommendation, are also selection factors.

Each class is carefully chosen as to have a diverse group of students with a broad range of experiences and backgrounds so as to enhance the learning experience of the class.

University of California, Irvine School of Medicine Degree Programs :

Medicine

Review

Yeni Rahayu

Great information and thanks for share it

Video Presentation

Dr. Ralph Clayman, Dean, UC Irvine School of Medicine